OBJECTIVE: The process of identifying, abstracting, and classifying cardiovascular disease (CVD) endpoints in the Jackson Heart Study (JHS) is described. METHOD: Trained interviewers conduct telephone annual followup interviews on or near the JHS exam 1 anniversary to ascertain any significant health events since the last JHS contact, including diagnostic tests, hospitalizations, or death. Information on cohort hospitalizations and deaths is transmitted to the medical record abstraction (MRA) unit who review death certificates and hospital records to identify CVD events in the cohort. Interviews with the next of kin and completed questionnaires by physicians and medical examiners or coroners are used to obtain information on deaths in the cohort. A computer-generated diagnosis with follow-up review and adjudication by trained medical personnel completes final, disease-specific event classification of hospitalized and fatal coronary heart disease (CHD), stroke, and congestive heart failure (CHF) events. DISCUSSION: Surveillance of this well-characterized group of African Americans for CVD events as well as sub- and preclinical manifestations of disease is a central aspect of the JHS. Particular focus is placed on the leading causes of CVD illness and death, including fatal and nonfatal CHD, stroke, and CHF.
OBJECTIVE: The process of identifying, abstracting, and classifying cardiovascular disease (CVD) endpoints in the Jackson Heart Study (JHS) is described. METHOD: Trained interviewers conduct telephone annual followup interviews on or near the JHS exam 1 anniversary to ascertain any significant health events since the last JHS contact, including diagnostic tests, hospitalizations, or death. Information on cohort hospitalizations and deaths is transmitted to the medical record abstraction (MRA) unit who review death certificates and hospital records to identify CVD events in the cohort. Interviews with the next of kin and completed questionnaires by physicians and medical examiners or coroners are used to obtain information on deaths in the cohort. A computer-generated diagnosis with follow-up review and adjudication by trained medical personnel completes final, disease-specific event classification of hospitalized and fatal coronary heart disease (CHD), stroke, and congestive heart failure (CHF) events. DISCUSSION: Surveillance of this well-characterized group of African Americans for CVD events as well as sub- and preclinical manifestations of disease is a central aspect of the JHS. Particular focus is placed on the leading causes of CVD illness and death, including fatal and nonfatal CHD, stroke, and CHF.
Authors: Ervin R Fox; Tandaw E Samdarshi; Solomon K Musani; Michael J Pencina; Jung Hye Sung; Alain G Bertoni; Vanessa Xanthakis; Pelbreton C Balfour; Satya S Shreenivas; Carolyn Covington; Philip R Liebson; Daniel F Sarpong; Kenneth R Butler; Thomas H Mosley; Wayne D Rosamond; Aaron R Folsom; David M Herrington; Ramachandran S Vasan; Herman A Taylor Journal: JAMA Cardiol Date: 2016-04-01 Impact factor: 14.676
Authors: Gabriel S Tajeu; John N Booth; Lisandro D Colantonio; Rebecca F Gottesman; George Howard; Daniel T Lackland; Emily C O'Brien; Suzanne Oparil; Joseph Ravenell; Monika M Safford; Samantha R Seals; Daichi Shimbo; Steven Shea; Tanya M Spruill; Rikki M Tanner; Paul Muntner Journal: Circulation Date: 2017-06-20 Impact factor: 29.690
Authors: Senthil Selvaraj; Sanjiv J Shah; Mark J Ommerborn; Cheryl R Clark; Michael E Hall; Robert J Mentz; Saadia Qazi; Jeremy M Robbins; Thomas N Skelton; Jiaying Chen; J Michael Gaziano; Luc Djoussé Journal: Circ Heart Fail Date: 2017-06 Impact factor: 8.790
Authors: John N Booth; Keith M Diaz; Samantha R Seals; Mario Sims; Joseph Ravenell; Paul Muntner; Daichi Shimbo Journal: Hypertension Date: 2016-06-27 Impact factor: 10.190
Authors: Ambarish Pandey; Neil Keshvani; Colby Ayers; Adolfo Correa; Mark H Drazner; Alana Lewis; Carlos J Rodriguez; Michael E Hall; Ervin R Fox; Robert J Mentz; Christopher deFilippi; Stephen L Seliger; Christie M Ballantyne; Ian J Neeland; James A de Lemos; Jarett D Berry Journal: JAMA Cardiol Date: 2019-01-01 Impact factor: 14.676
Authors: Stanford Mwasongwe; Yan Gao; Michael Griswold; James G Wilson; Abraham Aviv; Alexander P Reiner; Laura M Raffield Journal: Atherosclerosis Date: 2017-09-15 Impact factor: 5.162
Authors: Joseph Lunyera; John W Stanifer; Clemontina A Davenport; Dinushika Mohottige; Nrupen A Bhavsar; Julia J Scialla; Jane Pendergast; L Ebony Boulware; Clarissa Jonas Diamantidis Journal: Clin J Am Soc Nephrol Date: 2020-02-19 Impact factor: 8.237
Authors: Ravi V Shah; Aferdita Spahillari; Stanford Mwasongwe; J Jeffrey Carr; James G Terry; Robert J Mentz; Daniel Addison; Udo Hoffmann; Jared Reis; Jane E Freedman; Joao A C Lima; Adolfo Correa; Venkatesh L Murthy Journal: JAMA Cardiol Date: 2017-06-01 Impact factor: 14.676
Authors: Vanessa Xanthakis; Jung Hye Sung; Tandaw E Samdarshi; Alethea N Hill; Solomon K Musani; Mario Sims; Kamel A Ghraibeh; Philip R Liebson; Herman A Taylor; Ramachandran S Vasan; Ervin R Fox Journal: Diabetes Care Date: 2015-03-12 Impact factor: 19.112